Cell autonomous regulation of hippocampal circuitry via Aph1b-γ-secretase/neuregulin 1 signalling

eLife

Volumn 2014, Issue 3, 2014, Pages

  Fazzari, Pietro ^a,b   Snellinx, An ^a,b   Sabanov, Victor ^a   Ahmed, Tariq ^a   Serneels, Lutgarde ^a,b   Gartner, Annette ^a,b   Shariati, S Ali M ^a,b   Balschun, Detlef ^a   De Strooper, Bart ^a,b,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE; NEU DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DENDRITIC SPINE; ELECTROPHYSIOLOGICAL PROCEDURES; ELECTROPORATION; EMBRYO; GENE; GENE DELETION; GOLGI STAIN; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPUS; INTRACELLULAR SIGNALING; LONG TERM POTENTIATION; LOSS OF FUNCTION MUTATION; MOUSE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REGULATORY MECHANISM; SCHIZOPHRENIA; SPINE; SYNAPTIC TRANSMISSION; WESTERN BLOTTING; WHOLE CELL PATCH CLAMP;

EID: 84904011196     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.02196.001     Document Type: Article

References (36)

1. Arnsten AF, Wang MJ, Paspalas CD. 2012. Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron 76: 223-239. doi: 10.1016/j.neuron.2012.08.038.
2. Bao J, Wolpowitz D, Role LW, Talmage DA. 2003. Back signaling by the Nrg-1 intracellular domain. The Journal of Cell Biology 161: 1133-1141. doi: 10.1083/jcb.200212085.
3. Barros CS, Calabrese B, Chamero P, Roberts AJ, Korzus E, Lloyd K, Stowers L, Mayford M, Halpain S, Müller U. 2009. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proceedings of the National Academy of Sciences of the United States of America 106: 4507-4512. doi: 10.1073/pnas.0900355106.
4. Cahill ME, Jones KA, Rafalovich I, Xie Z, Barros CS, Muller U, Penzes P. 2012. Control of interneuron dendritic growth through NRG1/erbB4-mediated kalirin-7 disinhibition. Molecular Psychiatry 17: 1, 99-107. doi: 10.1038/mp.2011.35.
5. Chen Y, Hancock ML, Role LW, Talmage DA. 2010a. Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. The Journal of Neuroscience 30: 9199-9208. doi: 10.1523/JNEUROSCI.0605-10.2010.
6. Chen YJ, Johnson MA, Lieberman MD, Goodchild RE, Schobel S, Lewandowski N, Rosoklija G, Liu RC, Gingrich JA, Small S, Moore H, Dwork AJ, Talmage DA, Role LW. 2008. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. The Journal of Neuroscience 28: 6872-6883. doi: 10.1523/JNEUROSCI.1815-08.2008.
7. Chen YJ, Zhang M, Yin DM, Wen L, Ting A, Wang P, Lu YS, Zhu XH, Li SJ, Wu CY, Wang XM, Lai C, Xiong WC, Mei L, Gao TM. 2010b. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proceedings of the National Academy of Sciences of the United States of America 107: 21818-21823. doi: 10.1073/pnas.1010669107.
8. Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS. 2008. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophrenia Research 100: 270-280. doi: 10.1016/j.schres.2007.12.474.
9. Coolen MW, van Loo KM, Ellenbroek BA, Cools AR, Martens GJ. 2006. Ontogenic reduction of Aph-1b mRNA and gamma-secretase activity in rats with a complex neurodevelopmental phenotype. Molecular Psychiatry 11: 787-793. doi: 10.1038/sj.mp.4001846.
10. Coolen MW, Van Loo KM, Van Bakel NN, Pulford DJ, Serneels L, De Strooper B, Ellenbroek BA, Cools AR, Martens GJ. 2005. Gene dosage effect on gamma-secretase component Aph-1b in a rat model for neurodevelopmental disorders. Neuron 45: 497-503. doi: 10.1016/j.neuron.2004.12.054.
11. De Strooper B. 2003. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38: 9-12. doi: 10.1016/S0896-6273(03)00205-8.
12. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R. 1999. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522. doi: 10.1038/19083.
13. Dejaegere T, Serneels L, Schafer MK, Van Biervliet J, Horre K, Depboylu C, Alvarez-Fischer D, Herreman A, Willem M, Haass C, Höglinger GU, D'Hooge R, De Strooper B. 2008. Deficiency of Aph1b/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proceedings of the National Academy of Sciences of the United States of America 105: 9775-9780. doi: 10.1073/pnas.0800507105.
14. Del Pino I, Garcia-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martinez de Lagran M, Ciceri G, Gabaldón MV, Moratal D, Dierssen M, Canals S, Marín O, Rico B. 2013. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 79: 1152-1168. doi: 10.1016/j.neuron.2013.07.010.
15. Denayer E, Ahmed T, Brems H, Van Woerden G, Borgesius NZ, Callaerts-Vegh Z, Yoshimura A, Hartmann D, Elgersma Y, D'Hooge R, Legius E, Balschun D. 2008. Spred1 is required for synaptic plasticity and hippocampus-dependent learning. The Journal of Neuroscience 28: 14443-14449. doi: 10.1523/JNEUROSCI.4698-08.2008.
16. Eilam R, Pinkas-Kramarski R, Ratzkin BJ, Segal M, Yarden Y. 1998. Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain. Proceedings of the National Academy of Sciences of the United States of America 95: 1888-1893. doi: 10.1073/pnas.95.4.1888.
17. Fazzari P, Paternain AV, Valiente M, Pla R, Lujan R, Lloyd K, Lerma J, Marín O, Rico B. 2010. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 464: 1376-1380. doi: 10.1038/nature08928.
18. Glausier JR, Lewis DA. 2013. Dendritic spine pathology in schizophrenia. Neuroscience 251: 90-107. doi: 10.1016/j.neuroscience.2012.04.044.
19. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10: 40-68. doi: 10.1038/sj.mp.4001558.
20. Hatzimanolis A, McGrath JA, Wang R, Li T, Wong PC, Nestadt G, Wolyniec PS, Valle D, Pulver AE, Avramopoulos D. 2013. Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients. Translational Psychiatry 3: e264. doi: 10.1038/tp.2013.33.
21. Iijima T, Wu K, Witte H, Hanno-Iijima Y, Glatter T, Richard S, Scheiffele P. 2011. SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. Cell 147: 1601-1614. doi: 10.1016/j.cell.2011.11.028.
22. Lewis DA, Sweet RA. 2009. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. The Journal of Clinical Investigation 119: 706-716. doi: 10.1172/JCI37335.
23. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA. 2008. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in Neurosciences 31: 234-242. doi: 10.1016/j.tins.2008.02.005.
24. Marballi K, Cruz D, Thompson P, Walss-Bass C. 2012. Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings. PLOS ONE 7: e36431. doi: 10.1371/journal.pone.0036431.
25. Mei L, Xiong WC. 2008. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nature Reviews Neuroscience 9: 437-452. doi: 10.1038/nrn2392.
26. Ozaki M, Itoh K, Miyakawa Y, Kishida H, Hashikawa T. 2004. Protein processing and releases of neuregulin-1 are regulated in an activity-dependent manner. Journal of Neurochemistry 91: 176-188. doi: 10.1111/j.1471-4159.2004.02719.x.
27. Pedrique SP, Fazzari P. 2010. Nrg1 reverse signaling in cortical pyramidal neurons. The Journal of Neuroscience 30: 15005-15006. doi: 10.1523/JNEUROSCI.4669-10.2010.
28. Rico B, Marin O. 2011. Neuregulin signaling, cortical circuitry development and schizophrenia. Current Opinion in Genetics & Development 21: 262-270. doi: 10.1016/j.gde.2010.12.010.
29. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, Chattarji S, Kelleher RJ III, Kandel ER, Duff K, Kirkwood A, Shen J. 2004. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42: 23-36. doi: 10.1016/S0896-6273(04)00182-5.
30. Serneels L, Dejaegere T, Craessaerts K, Horre K, Jorissen E, Tousseyn T, Hébert S, Coolen M, Martens G, Zwijsen A, Annaert W, Hartmann D, De Strooper B. 2005. Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo. Proceedings of the National Academy of Sciences of the United States of America 102: 1719-1724. doi: 10.1073/pnas.0408901102.
31. Serneels L, Van Biervliet J, Craessaerts K, Dejaegere T, Horre K, Van Houtvin T, Esselmann H, Paul S, Schäfer MK, Berezovska O, Hyman BT, Sprangers B, Sciot R, Moons L, Jucker M, Yang Z, May PC, Karran E, Wiltfang J, D'Hooge R, De Strooper B. 2009. gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science 324: 639-642. doi: 10.1126/science.1171176.
32. Shariati SA, Lau P, Hassan BA, Muller U, Dotti CG, De Strooper B, Gärtner A. 2013. APLP2 regulates neuronal stem cell differentiation during cortical development. Journal of Cell Science 126: 1268-1277. doi: 10.1242/jcs.122440.
33. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K. 2002. Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics 71: 877-892. doi: 10.1086/342734.
34. Walss-Bass C, Liu W, Lew DF, Villegas R, Montero P, Dassori A, Leach RJ, Almasy L, Escamilla M, Raventos H. 2006. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biological Psychiatry 60: 548-553. doi: 10.1016/j.biopsych.2006.03.017.
35. Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ, Yin DM, Lai C, Terry AV Jnr, Vazdarjanova A, Xiong WC, Mei L. 2010. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proceedings of the National Academy of Sciences of the United States of America 107: 1211-1216. doi: 10.1073/pnas.0910302107.
36. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, Südhof TC, Shen J. 2009. Presenilins are essential for regulating neurotransmitter release. Nature 460: 632-636. doi: 10.1038/nature08177.